Skip to main content
Equibles
MBX logo

MBX · MBX Biosciences, Inc. · Earnings Call Transcripts & Audio

Track MBX — free

Use MBX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MBX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$58.62 +0.87 (+1.51%) At close · Sep 30
Russell 2000 member Rebalance outlook locked
Market Cap
$2.58B
Shares
48.16M
Volume · Sep 30 523.85K Avg daily vol (3M) 584.42K

MBX Biosciences, Inc. Earnings Call Transcripts

Quarterly earnings calls for MBX Biosciences, Inc. (MBX), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Conference
Investor event
2026-09-16
MBX Biosciences, Inc. (MBX) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-06
MBX Biosciences, Inc. (MBX) Q2 2026 Earnings Call
Diluted EPS
$-0.78
Audio Transcript Slides 8-K10-Q
Capital Markets Day
Investor event
2026-06-12
MBX Biosciences, Inc. (MBX) June 2026 Capital Markets Day Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
MBX Biosciences, Inc. (MBX) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-11
MBX Biosciences, Inc. (MBX) Q1 2026 Earnings Call
Diluted EPS
$-0.50
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-12
MBX Biosciences, Inc. (MBX) Q4 2025 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Conference
Investor event
2026-03-11
MBX Biosciences, Inc. (MBX) March 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q3
2025-11-24
MBX Biosciences, Inc. (MBX) Q3 2025 Earnings Call
Confident tone Phase 2 VAIL Trial Topline Results Canbuperatide / Once-Weekly PTH Therapy Open-Label Extension / Durability
Diluted EPS
$-0.63
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-09-22
MBX Biosciences, Inc. (MBX) Q2 2025 Earnings Call Transcript
Confident tone Once-weekly dosing differentiation Open-label extension durability Phase 2 AVAIL trial efficacy results
Diluted EPS
$-0.58
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
MBX Biosciences, Inc. (MBX) Q1 2025 Earnings Call
Diluted EPS
$-0.71
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-17
MBX Biosciences, Inc. (MBX) Q4 2024 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
MBX Biosciences, Inc. (MBX) Q3 2024 Earnings Call
Diluted EPS
$-2.78
Audio Transcript Slides 8-K10-Q
Showing 1–12 of 12 earnings calls
Key facts CIK 1776111 CUSIP 55287L101 13F (30d) 3 filings 3 filers Visit website Investor relations